166 related articles for article (PubMed ID: 36928361)
1. Taurodeoxycholic acid-YAP1 upregulates OTX1 in promoting gallbladder cancer malignancy through IFITM3-dependent AKT activation.
Yang R; Yang L; Long M; Wu F; Shi Y; Xia R; Lv J; Zhang Y; Lei Y; Jiao Y; Zhao C; Wang H; Wei W
Oncogene; 2023 May; 42(18):1466-1477. PubMed ID: 36928361
[TBL] [Abstract][Full Text] [Related]
2. TASP1 Promotes Gallbladder Cancer Cell Proliferation and Metastasis by Up-regulating FAM49B via PI3K/AKT Pathway.
Zhang Y; Du P; Li Y; Zhu Q; Song X; Liu S; Hao J; Liu L; Liu F; Hu Y; Jiang L; Ma Q; Lu W; Liu Y
Int J Biol Sci; 2020; 16(5):739-751. PubMed ID: 32071545
[TBL] [Abstract][Full Text] [Related]
3. Yes-associated protein 1 (YAP1) promotes human gallbladder tumor growth via activation of the AXL/MAPK pathway.
Li M; Lu J; Zhang F; Li H; Zhang B; Wu X; Tan Z; Zhang L; Gao G; Mu J; Shu Y; Bao R; Ding Q; Wu W; Dong P; Gu J; Liu Y
Cancer Lett; 2014 Dec; 355(2):201-9. PubMed ID: 25218593
[TBL] [Abstract][Full Text] [Related]
4. KIF11 promotes cell proliferation via ERBB2/PI3K/AKT signaling pathway in gallbladder cancer.
Wei D; Rui B; Qingquan F; Chen C; Ping HY; Xiaoling S; Hao W; Jun G
Int J Biol Sci; 2021; 17(2):514-526. PubMed ID: 33613109
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-4516 suppresses pancreatic cancer development via negatively regulating orthodenticle homeobox 1.
Chen S; Xu M; Zhao J; Shen J; Li J; Liu Y; Cao G; Ma J; He W; Chen X; Shan T
Int J Biol Sci; 2020; 16(12):2159-2169. PubMed ID: 32549762
[TBL] [Abstract][Full Text] [Related]
6. Orthodenticle homeobox OTX1 is a potential prognostic biomarker for bladder cancer.
Jiang L; Zuo Z; Lin J; Yang C
Bioengineered; 2021 Dec; 12(1):6559-6571. PubMed ID: 34559577
[TBL] [Abstract][Full Text] [Related]
7. OTX1 promotes colorectal cancer progression through epithelial-mesenchymal transition.
Yu K; Cai XY; Li Q; Yang ZB; Xiong W; Shen T; Wang WY; Li YF
Biochem Biophys Res Commun; 2014 Jan; 444(1):1-5. PubMed ID: 24388989
[TBL] [Abstract][Full Text] [Related]
8. Fibronectin promotes cell proliferation and invasion through mTOR signaling pathway activation in gallbladder cancer.
Cao Y; Liu X; Lu W; Chen Y; Wu X; Li M; Wang XA; Zhang F; Jiang L; Zhang Y; Hu Y; Xiang S; Shu Y; Bao R; Li H; Wu W; Weng H; Yen Y; Liu Y
Cancer Lett; 2015 May; 360(2):141-50. PubMed ID: 25657110
[TBL] [Abstract][Full Text] [Related]
9. LncRNA-HGBC stabilized by HuR promotes gallbladder cancer progression by regulating miR-502-3p/SET/AKT axis.
Hu YP; Jin YP; Wu XS; Yang Y; Li YS; Li HF; Xiang SS; Song XL; Jiang L; Zhang YJ; Huang W; Chen SL; Liu FT; Chen C; Zhu Q; Chen HZ; Shao R; Liu YB
Mol Cancer; 2019 Nov; 18(1):167. PubMed ID: 31752906
[TBL] [Abstract][Full Text] [Related]
10. OTX1 exerts an oncogenic role and is negatively regulated by miR129-5p in laryngeal squamous cell carcinoma.
Tu XP; Li H; Chen LS; Luo XN; Lu ZM; Zhang SY; Chen SH
BMC Cancer; 2020 Aug; 20(1):794. PubMed ID: 32838760
[TBL] [Abstract][Full Text] [Related]
11. TROP2 promotes proliferation, migration and metastasis of gallbladder cancer cells by regulating PI3K/AKT pathway and inducing EMT.
Li X; Teng S; Zhang Y; Zhang W; Zhang X; Xu K; Yao H; Yao J; Wang H; Liang X; Hu Z
Oncotarget; 2017 Jul; 8(29):47052-47063. PubMed ID: 28423362
[TBL] [Abstract][Full Text] [Related]
12. OTX1 promotes tumorigenesis and progression of cervical cancer by regulating the Wnt signaling pathway.
Zhou L; Li H; Zhang D; Chen L; Dong H; Yuan Y; Wang T
Oncol Rep; 2022 Nov; 48(5):. PubMed ID: 36177903
[TBL] [Abstract][Full Text] [Related]
13. miR-4461 inhibits the progression of Gallbladder carcinoma via regulating EGFR/AKT signaling.
Yan X; Yang P; Liu H; Zhao Y; Wu Z; Zhang B
Cell Cycle; 2022 Jun; 21(11):1166-1177. PubMed ID: 35196196
[TBL] [Abstract][Full Text] [Related]
14. SP/NK-1R promotes gallbladder cancer cell proliferation and migration.
Deng XT; Tang SM; Wu PY; Li QP; Ge XX; Xu BM; Wang HS; Miao L
J Cell Mol Med; 2019 Dec; 23(12):7961-7973. PubMed ID: 30903649
[TBL] [Abstract][Full Text] [Related]
15. Dioscin Induces Gallbladder Cancer Apoptosis by Inhibiting ROS-Mediated PI3K/AKT Signalling.
Song X; Wang Z; Liang H; Zhang W; Ye Y; Li H; Hu Y; Zhang Y; Weng H; Lu J; Wang X; Li M; Liu Y; Gu J
Int J Biol Sci; 2017; 13(6):782-793. PubMed ID: 28656003
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2.
Wang SH; Wu XC; Zhang MD; Weng MZ; Zhou D; Quan ZW
Tumour Biol; 2016 Jul; 37(7):9721-30. PubMed ID: 26803515
[TBL] [Abstract][Full Text] [Related]
17. CCL18 secreted from M2 macrophages promotes migration and invasion via the PI3K/Akt pathway in gallbladder cancer.
Zhou Z; Peng Y; Wu X; Meng S; Yu W; Zhao J; Zhang H; Wang J; Li W
Cell Oncol (Dordr); 2019 Feb; 42(1):81-92. PubMed ID: 30276551
[TBL] [Abstract][Full Text] [Related]
18. DMBT1 suppresses progression of gallbladder carcinoma through PI3K/AKT signaling pathway by targeting PTEN.
Sheng S; Jiwen W; Dexiang Z; Bohao Z; Yueqi W; Han L; Xiaoling N; Tao S; Liu H
Biosci Biotechnol Biochem; 2019 Dec; 83(12):2257-2264. PubMed ID: 31411121
[TBL] [Abstract][Full Text] [Related]
19. Liensinine induces gallbladder cancer apoptosis and G2/M arrest by inhibiting ZFX-induced PI3K/AKT pathway.
Shen Y; Bian R; Li Y; Gao Y; Liu Y; Xu Y; Song X; Zhang Y
Acta Biochim Biophys Sin (Shanghai); 2019 Jun; 51(6):607-614. PubMed ID: 31074773
[TBL] [Abstract][Full Text] [Related]
20. A novel PI3K/AKT signaling axis mediates Nectin-4-induced gallbladder cancer cell proliferation, metastasis and tumor growth.
Zhang Y; Liu S; Wang L; Wu Y; Hao J; Wang Z; Lu W; Wang XA; Zhang F; Cao Y; Liang H; Li H; Ye Y; Ma Q; Zhao S; Shu Y; Bao R; Jiang L; Hu Y; Zhou J; Chen L; Liu Y
Cancer Lett; 2016 May; 375(1):179-189. PubMed ID: 26949052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
